GENZ
GENZ Articles
We are seeing many key movers in the BioHealth space today as drug and biotech stocks often exhibit the most volatility of any sector. Today’s BioHealth Business Daily includes the key moves and...
Published:
Last Updated:
Updated throughout the day. Goldman Sachs (GS) has begun PR efforts to improve its image (NYPost). Stanley Fink, the former chief executive of Man Group, and Larry Hite may start a new hedge fund in...
Published:
These are this Wednesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Baidu Inc. (NASDAQ: BIDU) Reiterated Buy but target raised to $550 at Goldman...
Published:
Last Updated:
There are many companies that deserved to be on this weekend’s slate of unusual suspects that have key current developments to watch in this coming week. Some are unusual trading activity, some...
Published:
Last Updated:
Updated throughout the day. The auto task force says GM and Chrysler are recovering ahead of schedule (Reuters) Carl Icahn may force a sale of Take-Two Interactive (NASDAQ:TTWO) after buying 11% of...
Published:
Last Updated:
It was early in October before earnings season kicked off into full thrust when we first reviewed many large or actively traded stocks which had not participated in the stock market rally of 2009. ...
Published:
Last Updated:
These are this morning’s top pre-market analyst upgrades, downgrades, and initiations seen in Wall Street research calls: Abercrombie & Fitch (ANF) Raised to Outperform at FBR. AGA Medical...
Published:
Last Updated:
Here we are going into yet another earnings season. We saw Monday how the market has rallied significantly from the March lows and the major indexes are even up in positive territory for the 2009...
Published:
These are the top 10 analyst upgrades, downgrades, and initiations we have seen early this Monday morning: Alliant Techsystems (ATK) Started as Buy at Jefferies. Celgene (CELG) raised to Outperform...
Published:
These are this Friday’s top analyst downgrades and cautious research calls we have seen from Wall Street firms: athenahealth (ATHN) Cut to Sell at Auriga. Charles Schwab (SCHW) Cut to Sell at...
Published:
These are the top ten analyst research initiations, upgrades, and downgrades we have seen from top Wall Street firms early this Wednesday morning: Biogen-Idec (BIIB) Started as Underperform at...
Published:
These are Monday’s top day trader and active trader alert stocks. We have links through to each with more detailed price/volume analysis over at VSinvestor.com: American International Group...
Published:
Last Updated:
These are some of the top early-bird analyst downgrades and cautious research calls we have seen from Wall Street analysts early this Monday morning: Assured Guaranty (AGO) Cut to Neutral at UBS....
Published:
It usually takes an event or a series of events for biotech stocks to ever look cheap compared to the overall market or even to sub-sectors within health care. They generally trade at higher...
Published:
Last Updated:
It’s the weekend, and that brings about the review of “the unusual suspects” for strange activity or for being key stocks under review for the week ahead. There are some old hat names here...
Published:
Last Updated: